Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2004 1
2015 1
2018 1
2019 1
2024 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
The following term was not found in PubMed: /
Page 1
Topical dorzolamide for macular holes: A randomised, double-blind, placebo-controlled trial.
Lee YM, Bahrami B, Baranage D, Sivagurunathan PD, Wong W, Bausili MM, Agrawal S, Gilhotra JS, Durkin S, Sia D, Selva D, Lake S, Casson RJ, Chan WO. Lee YM, et al. Clin Exp Ophthalmol. 2024 Nov;52(8):870-879. doi: 10.1111/ceo.14432. Epub 2024 Aug 15. Clin Exp Ophthalmol. 2024. PMID: 39145570 Clinical Trial.
Participants in both arms used topical dorzolamide 2% or saline thrice daily for 8 weeks with monthly OCT. Those with persisting FTMH underwent vitrectomy with ILM peel and gas tamponade. ...No serious adverse events were reported in either group. CONCLUSION: Topical do …
Participants in both arms used topical dorzolamide 2% or saline thrice daily for 8 weeks with monthly OCT. Those with persisting FTMH …
Do we need day-1 postoperative follow-up after cataract surgery?
Grzybowski A, Kanclerz P. Grzybowski A, et al. Graefes Arch Clin Exp Ophthalmol. 2019 May;257(5):855-861. doi: 10.1007/s00417-018-04210-0. Epub 2018 Dec 19. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 30569320 Review.
When eliminating the POD1, visit individuals should receive topically a potent steroid (preferably prednisolone or dexamethasone). Applying a combination of topical dorzolamide/timolol and brinzolamide postoperatively in patients with glaucoma would be recommended, particu …
When eliminating the POD1, visit individuals should receive topically a potent steroid (preferably prednisolone or dexamethasone). Applying …
Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure. Dorzolamide Comparison Study Group.
Rusk C, Sharpe E, Laurence J, Polis A, Adamsons I. Rusk C, et al. Clin Ther. 1998 May-Jun;20(3):454-66. doi: 10.1016/s0149-2918(98)80055-6. Clin Ther. 1998. PMID: 9663361 Clinical Trial.
A multicenter, parallel-design, randomized, double-masked study was conducted to compare the efficacy and safety of 2% dorzolamide with those of 0.5% betaxolol in the treatment of elevated intraocular pressure (i.o.p). ...This study confirmed the similar IOP-lowering effec …
A multicenter, parallel-design, randomized, double-masked study was conducted to compare the efficacy and safety of 2% dorzolamide wi …
Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label, parallel-group, multicenter study in Latin America.
Susanna R Jr, Sheu WP; Latin American Glaucoma Society. Susanna R Jr, et al. Clin Ther. 2004 May;26(5):755-68. doi: 10.1016/s0149-2918(04)90075-6. Clin Ther. 2004. PMID: 15220019 Clinical Trial.
The primary efficacy outcome was change in diurnal IOP (the mean of IOP measurements) from baseline to week 8. Adverse effect (AE) data were recorded at each visit. RESULTS: A total of 229 patients were randomized (latanoprost, n = 112; dorzolamide/timolol, n = 117) …
The primary efficacy outcome was change in diurnal IOP (the mean of IOP measurements) from baseline to week 8. Adverse effect (AE) da …
Impact of supply problems of preservative-free glaucoma medications on patients and hospital staff.
Shah S, Theodossiades J, Chapman K, Murdoch I. Shah S, et al. Ophthalmic Physiol Opt. 2015 Mar;35(2):236-41. doi: 10.1111/opo.12180. Ophthalmic Physiol Opt. 2015. PMID: 25761582 Free article.
From early 2011 patients attending Moorfields Eye Hospital, London, UK, started to report recurring problems with the supply of the following preservative-free glaucoma medications: Timolol 0.25% (Timoptol 0.25%, MSD UK); Dorzolamide (Trusopt, MSD UK); Dorzolamide a …
From early 2011 patients attending Moorfields Eye Hospital, London, UK, started to report recurring problems with the supply of the followin …